Event Type: The document pertains to an Earnings Call held by the company.
Event Date and Time: The earnings call was held on November 6, 2026. A specific time and time zone were not disclosed in the announcement.
Purpose of Event: The call was held for a discussion on the company's operational and financial performance for the quarter and half year ended September 30, 2026 (Q2 FY26).
Availability of Materials: The audio recording of the earnings call has been made available on the company's investor relations website at: https://www.supriyalifescience.com/ir-financial.php.
Management Participants: The announcement does not list any specific management participants or their designations.
UPSI Statement: The document does not contain any specific language indicating whether unpublished price sensitive information (UPSI) was or was not shared during the call.
Additional Notes Section
The document is a formal regulatory submission (a letter) addressed to both BSE Limited and the National Stock Exchange of India Limited.
The letter is signed digitally by Prachi Sathe, who is identified as the Company Secretary & Compliance Officer.
The announcement contains no financial data, highlights, guidance references, or presentation summaries. It solely intimates the availability of the call recording.
The company's corporate office and factory addresses, along with contact details and corporate identifiers (CIN: L51900MH2008PLC180452, GSTIN: 27AALCS8686A1ZX), are provided in the footer.
